Therapeutics: P selectin glycoprotein ligand-1 (PSGL-1; CD162; SELPLG)

Infectious disease

INDICATION: Viral infection; melanoma

Mouse studies suggest PSGL-1 inhibitors could help treat chronic viral infections or melanoma.